Statistics
Publications
2
Citations
124
H-Index
2
Active since
2008
Affiliations
Faculty of 1000 (United States)(Current)
Barry Sloan is an author at Faculty of 1000 (United States) specializing in cultural studies, urban history, and cancer therapeutics.
Publications per year
2008–2015
2
2
Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy.
Barry Sloan, Noah Scheinfeld · PubMed · 2008 · 112 citations
1–2 of 2